how the treatment and management of all changes with age
Published 1 year ago • 103 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
2:09
advances in the management of fit adults with aml
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
5:10
why do our bodies age? - monica menesini
-
2:23
understanding parkinson's disease
-
3:19
first-line treatment selection in myelofibrosis
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
3:01
treatment approaches for asct-eligible myeloma patients in the frontline
-
2:57
novel targeted therapies for the treatment of bpdcn
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:16
current and future treatment approaches for hr-mds
-
2:02
recent advances in all treatment
-
0:58
management strategies for acute and chronic gvhd following allosct
-
2:43
the management of advanced phase mpns
-
3:07
how age as a prognostic factor affects treatment options for all
-
3:16
improving upon the standard of care for patients with richter’s transformation
-
1:18
the epidemiology and treatment of chronic gvhd post-allosct
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:11
making clinical decisions with patients